PTC Therapeutics, Inc. (PTCT)
NASDAQ: PTCT · Real-Time Price · USD
73.31
+2.46 (3.47%)
At close: Aug 7, 2026, 4:00 PM EDT
72.00
-1.31 (-1.79%)
After-hours: Aug 7, 2026, 7:34 PM EDT
PTC Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 1,050 | 984.65 | 779.71 | 594 | 279.83 | 189.72 |
Short-Term Investments | 1,179 | 960.72 | 359.99 | 282.74 | 130.87 | 583.66 |
Cash & Short-Term Investments | 2,229 | 1,945 | 1,140 | 876.74 | 410.71 | 773.38 |
Cash Growth | 12.06% | 70.69% | 29.99% | 113.47% | -46.89% | -29.93% |
Accounts Receivable | 239.04 | 181.62 | 158.55 | 160.82 | 155.61 | 110.46 |
Inventory | 91.35 | 79.65 | 23.19 | 30.58 | 21.81 | 15.86 |
Other Current Assets | 57.88 | 67.31 | 44.09 | 150.49 | 105.66 | 54.68 |
Total Current Assets | 2,617 | 2,274 | 1,366 | 1,219 | 693.79 | 954.37 |
Net Property, Plant & Equipment | 126.27 | 135.42 | 117.66 | 178.99 | 175.02 | 130.01 |
Other Intangible Assets | 402.93 | 388.75 | 118.79 | 379.5 | 705.89 | 724.84 |
Goodwill | 82.34 | 82.34 | 82.34 | 82.34 | 82.34 | 82.34 |
Other Long-Term Assets | 21.58 | 18.3 | 20.7 | 36.25 | 48.58 | 46.5 |
Total Assets | 3,250 | 2,899 | 1,705 | 1,896 | 1,706 | 1,938 |
Accounts Payable | 382.25 | 381.27 | 304.29 | 391.98 | 320.37 | 288.78 |
Current Portion of Long-Term Debt | 55.45 | 286.63 | - | - | - | 149.54 |
Current Portion of Leases | 17.97 | 15.48 | 13.36 | 16 | 12.37 | 10.27 |
Unearned Revenue | 1.19 | 2.04 | 5.51 | 0.8 | 1.35 | - |
Other Current Liabilities | 314.22 | 283 | 257.82 | 194.31 | 72.15 | 60.75 |
Total Current Liabilities | 771.07 | 968.43 | 580.98 | 603.1 | 406.24 | 509.35 |
Long-Term Debt | 535.52 | - | 285.41 | 284.21 | 571.72 | 281.89 |
Long-Term Leases | 87.53 | 96.58 | 90.52 | 114.81 | 119.54 | 93.67 |
Other Long-Term Liabilities | 2,022 | 2,039 | 1,846 | 1,712 | 955.21 | 1,052 |
Total Long-Term Liabilities | 2,645 | 2,136 | 2,222 | 2,111 | 1,646 | 1,427 |
Total Liabilities | 3,416 | 3,104 | 2,803 | 2,714 | 2,053 | 1,937 |
Common Stock | 0.08 | 0.08 | 0.08 | 0.08 | 0.07 | 0 |
Additional Paid-in Capital | 2,712 | 2,748 | 2,575 | 2,466 | 2,305 | 2,124 |
Accumulated Other Comprehensive Income | 6.02 | 10.5 | -25.89 | -1.29 | 4.8 | -24.28 |
Retained Earnings | -2,884 | -2,964 | -3,647 | -3,284 | -2,657 | -2,098 |
Shareholders' Equity | -165.36 | -205.31 | -1,098 | -818.56 | -347.09 | 1.37 |
Total Liabilities & Equity | 3,250 | 2,899 | 1,705 | 1,896 | 1,706 | 1,938 |
Total Debt | 696.47 | 398.7 | 389.3 | 415.03 | 703.63 | 535.38 |
Net Cash (Debt) | 1,533 | 1,547 | 750.4 | 461.71 | -292.92 | 238 |
Net Cash Growth | -4.27% | 106.11% | 62.52% | - | - | -65.16% |
Net Cash Per Share | 17.91 | 17.51 | 9.77 | 6.17 | -4.08 | 3.38 |
Book Value | -165.36 | -205.31 | -1,098 | -818.56 | -347.09 | 1.37 |
Book Value Per Share | -1.93 | -2.32 | -14.29 | -10.94 | -4.84 | 0.02 |
Tangible Book Value | -650.63 | -676.41 | -1,299 | -1,280 | -1,135 | -805.81 |
Tangible Book Value Per Share | -7.60 | -7.66 | -16.91 | -17.11 | -15.83 | -11.44 |